The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and developmental progress towards clinical and commercial approval.
Discover the realms of new infectious disease platforms, combating oncological targets and cell therapies across 4 dedicated tracks of content in Discovery, Pre-Clinical Development, Clinical Development and Manufacturing & CMC, as your one-stop-shop scientific content and partnering forum to aid the progress of pipelines in 2025 towards the clinic and ultimately patients in need.
Download the event guide for full details: https://ter.li/esarrv